BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 36915996)

  • 21. Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B.
    Huang C; Zhu XD; Ji Y; Ding GY; Shi GM; Shen YH; Zhou J; Fan J; Sun HC
    BMC Cancer; 2017 Jan; 17(1):58. PubMed ID: 28095820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Updated treatment approach to hepatocellular carcinoma.
    Llovet JM
    J Gastroenterol; 2005 Mar; 40(3):225-35. PubMed ID: 15830281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatectomy for ruptured hepatocellular carcinoma classified as Barcelona Clinic Liver Cancer stage 0/A: The optimal treatment.
    Xia F; Huang Z; Zhang Q; Ndhlovu E; Zhang M; Chen X; Chen Y; Zhang B; Zhu P
    Eur J Surg Oncol; 2022 Sep; 48(9):2014-2022. PubMed ID: 35595579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal staging system for predicting the prognosis of patients with hepatocellular carcinoma in China: a retrospective study.
    Su L; Zhou T; Zhang Z; Zhang X; Zhi X; Li C; Wang Q; Jia C; Shi W; Yue Y; Gao Y; Cheng B
    BMC Cancer; 2016 Jul; 16():424. PubMed ID: 27387757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TNM/Okuda/Barcelona/UNOS/CLIP International Multidisciplinary Classification of Hepatocellular Carcinoma: concepts, perspectives, and radiologic implications.
    Faria SC; Szklaruk J; Kaseb AO; Hassabo HM; Elsayes KM
    Abdom Imaging; 2014 Oct; 39(5):1070-87. PubMed ID: 24695938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-naïve patients with hepatocellular carcinoma.
    Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Park MS; Kim EH; Seong J; Lee DY; Han KH
    Liver Int; 2012 Aug; 32(7):1120-7. PubMed ID: 22524688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort study.
    Borzio M; Dionigi E; Rossini A; Marignani M; Sacco R; De Sio I; Bertolini E; Francica G; Giacomin A; Parisi G; Vicari S; Toldi A; Salmi A; Boccia S; Mitra M; Fornari F
    Hepatology; 2018 Jun; 67(6):2215-2225. PubMed ID: 29165831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.
    Huang YH; Chen CH; Chang TT; Chen SC; Wang SY; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Lee PC; Chau GY; Lui WY; Lee SD; Wu JC
    J Gastroenterol Hepatol; 2005 May; 20(5):765-71. PubMed ID: 15853992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic prediction in patients with hepatocellular carcinoma.
    Sala M; Forner A; Varela M; Bruix J
    Semin Liver Dis; 2005; 25(2):171-80. PubMed ID: 15918146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hong Kong Liver Cancer Staging System Is Associated With Better Performance for Hepatocellular Carcinoma: Special Emphasis on Viral Etiology.
    Liu PH; Hsu CY; Lee YH; Su CW; Hsia CY; Huang YH; Chiou YY; Lin HC; Huo TI
    Medicine (Baltimore); 2015 Oct; 94(41):e1772. PubMed ID: 26469917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel prognostic nomogram based on microvascular invasion and hematological biomarkers to predict survival outcome for hepatocellular carcinoma patients.
    Li X; Huang H; Yu X; Chen P; Ouyang J; Huang B
    Surg Oncol; 2020 Jun; 33():51-57. PubMed ID: 32561099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.
    Choi HJ; Kim DG; Na GH; Han JH; Hong TH; You YK
    World J Gastroenterol; 2013 Aug; 19(29):4737-44. PubMed ID: 23922471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of four current staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection: Okuda, CLIP, TNM and CUPI.
    Lu W; Dong J; Huang Z; Guo D; Liu Y; Shi S
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1874-8. PubMed ID: 18752560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification.
    Tsilimigras DI; Bagante F; Sahara K; Moris D; Hyer JM; Wu L; Ratti F; Marques HP; Soubrane O; Paredes AZ; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    Ann Surg Oncol; 2019 Oct; 26(11):3693-3700. PubMed ID: 31267302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nomogram prediction of individual prognosis of patients with hepatocellular carcinoma.
    Wan G; Gao F; Chen J; Li Y; Geng M; Sun L; Liu Y; Liu H; Yang X; Wang R; Feng Y; Wang X
    BMC Cancer; 2017 Jan; 17(1):91. PubMed ID: 28143427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of current staging systems for advanced hepatocellular carcinoma not amendable to locoregional therapy as inclusion criteria for clinical trials.
    Li X; Dong M; Lin Q; Chen ZH; Ma XK; Xing YF; Wan XB; Wen JY; Wei L; Chen J; Wu XY
    Asia Pac J Clin Oncol; 2013 Mar; 9(1):86-92. PubMed ID: 23279888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barcelona Clinic Liver Cancer outperforms Hong Kong Liver Cancer staging of hepatocellular carcinoma in multiethnic Asians: Real-world perspective.
    Li JW; Goh BG; Chang PE; Tan CK
    World J Gastroenterol; 2017 Jun; 23(22):4054-4063. PubMed ID: 28652658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Nomogram for Hepatitis B Virus-related Hepatocellular Carcinoma With Adjuvant Transarterial Chemoembolization After Radical Resection.
    Huang J; Liu FC; Li L; Yuan SX; Yang Y; Jiang BG; Liu H; Pan ZY
    Am J Clin Oncol; 2020 Jan; 43(1):20-27. PubMed ID: 31633514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A model to estimate survival in ambulatory patients with hepatocellular carcinoma: Can it predict the natural course of hepatocellular carcinoma?
    Choi WM; Yu SJ; Ahn H; Cho H; Cho YY; Lee M; Yoo JJ; Cho Y; Lee DH; Cho EJ; Lee JH; Kim YJ; Yoon JH
    Dig Liver Dis; 2017 Nov; 49(11):1273-1279. PubMed ID: 28807489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of eight different clinical staging systems associated with overall survival of chinese patients with hepatocellular carcinoma.
    Zhao JJ; Yan T; Zhao H; Zhou JG; Huang Z; Zhang YF; Li Y; Li ZY; Bi XY; Cai JQ
    Chin Med J (Engl); 2015 Feb; 128(3):316-21. PubMed ID: 25635426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.